{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:47:25Z","timestamp":1790624845744,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002519","name":"Korea University of Technology and Education","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/501100002519","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00296-016-3468-5","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T09:37:14Z","timestamp":1458553034000},"page":"663-672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"36","author":[{"given":"Young Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwan Gyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"3468_CR1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600\u2013610","journal-title":"Arthritis Care Res"},{"key":"3468_CR2","first-page":"S117","volume":"33","author":"A Rossi","year":"2015","unstructured":"Rossi A, Di Lollo A, Guzzo M, Giacomelli C, Atzeni F, Bazzichi L, Di Franco M (2015) Fibromyalgia and nutrition: what news. Clin Exp Rheumatol 33:S117\u2013S125","journal-title":"Clin Exp Rheumatol"},{"key":"3468_CR3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.mayocp.2015.03.014","volume":"90","author":"DJ Clauw","year":"2015","unstructured":"Clauw DJ (2015) Fibromyalgia and related conditions. Mayo Clin Proc 90:680\u2013692","journal-title":"Mayo Clin Proc"},{"key":"3468_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1124\/jpet.115.227298","volume":"355","author":"TC Theoharides","year":"2015","unstructured":"Theoharides TC, Tsilioni I, Arbetman L, Panagiotidou S, Stewart JM, Gleason RM, Russell IJ (2015) Fibromyalgia syndrome in need of effective treatments. J Pharmacol Exp Ther 355:255\u2013263","journal-title":"J Pharmacol Exp Ther"},{"key":"3468_CR5","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14656566.2015.1047343","volume":"16","author":"EP Calandre","year":"2015","unstructured":"Calandre EP, Rico-Villademoros F, Slim M (2015) An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opin Pharmacother 16:1347\u20131368","journal-title":"Expert Opin Pharmacother"},{"key":"3468_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1471-0528.2006.00877.x","volume":"113","author":"B Schuessler","year":"2006","unstructured":"Schuessler B (2006) What do we know about duloxetine\u2019s mode of action? Evidence from animals to humans. BJOG Int J Obstet Gynaecol 113:5\u20139","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"3468_CR7","first-page":"637","volume":"7","author":"RJ Leo","year":"2006","unstructured":"Leo RJ, Brooks VL (2006) Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain. Curr Opin Investig Drugs 7:637\u2013642","journal-title":"Curr Opin Investig Drugs"},{"key":"3468_CR8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopsych.2003.07.006","volume":"55","author":"SN Vaishnavi","year":"2004","unstructured":"Vaishnavi SN, Nemeroff CB, Plott SJ, Rao SG, Kranzler J, Owens MJ (2004) Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry 55:320\u2013322","journal-title":"Biol Psychiatry"},{"key":"3468_CR9","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2165\/00003495-200868150-00009","volume":"68","author":"KA Lyseng-Williamson","year":"2008","unstructured":"Lyseng-Williamson KA, Siddiqui MA (2008) Pregabalin: a review of its use in fibromyalgia. Drugs 68:2205\u20132223","journal-title":"Drugs"},{"key":"3468_CR10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpain.2010.01.002","volume":"11","author":"W H\u00e4user","year":"2010","unstructured":"H\u00e4user W, Petzke F, Sommer C (2010) Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain 11:505\u2013521","journal-title":"J Pain"},{"key":"3468_CR11","first-page":"1","volume":"1","author":"MP Lunn","year":"2014","unstructured":"Lunn MP, Hughes RA, Wiffen PJ (2014) Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev (CDSR) 1:1\u2013126","journal-title":"Cochrane Database Syst Rev (CDSR)"},{"key":"3468_CR12","first-page":"1","volume":"10","author":"M Cording","year":"2015","unstructured":"Cording M, Derry S, Phillips T, Moore RA, Wiffen PJ (2015) Milnacipran for pain in fibromyalgia in adults. Cochrane Database Syst Rev (CDSR) 10:1\u201370","journal-title":"Cochrane Database Syst Rev (CDSR)"},{"key":"3468_CR13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2710.2009.01144.x","volume":"35","author":"TG Tzellos","year":"2010","unstructured":"Tzellos TG, Toulis KA, Goulis DG, Papazisis G, Zampeli VA, Vakfari A, Kouvelas D (2010) Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. J Clin Pharm Ther 35:639\u2013656","journal-title":"J Clin Pharm Ther"},{"key":"3468_CR14","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1007\/s11033-010-0477-4","volume":"38","author":"YH Lee","year":"2011","unstructured":"Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2011) Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 38:3643\u20133651","journal-title":"Mol Biol Rep"},{"key":"3468_CR15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00296-007-0320-y","volume":"27","author":"YH Lee","year":"2007","unstructured":"Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27:827\u2013833","journal-title":"Rheumatol Int"},{"key":"3468_CR16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00296-010-1678-9","volume":"32","author":"YH Lee","year":"2012","unstructured":"Lee YH, Choi SJ, Ji JD, Song GG (2012) Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int 32:417\u2013426","journal-title":"Rheumatol Int"},{"key":"3468_CR17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","volume":"331","author":"DM Caldwell","year":"2005","unstructured":"Caldwell DM, Ades A, Higgins J (2005) Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ Br Med J 331:897","journal-title":"BMJ Br Med J"},{"key":"3468_CR18","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00296-015-3291-4","volume":"35","author":"YH Lee","year":"2015","unstructured":"Lee YH, Bae SC, Song GG (2015) Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Rheumatol Int 35:1965\u20131974","journal-title":"Rheumatol Int"},{"key":"3468_CR19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum Arthritis Care Res 33:160\u2013172","journal-title":"Arthritis Rheum Arthritis Care Res"},{"key":"3468_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1\u201312","journal-title":"Control Clin Trials"},{"key":"3468_CR21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264\u2013269","journal-title":"Ann Intern Med"},{"key":"3468_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-3-110","volume":"3","author":"S Brown","year":"2014","unstructured":"Brown S, Hutton B, Clifford T, Coyle D, Grima D, Wells G, Cameron C (2014) A Microsoft-Excel-based tool for running and critically appraising network meta-analyses\u2014an overview and application of NetMetaXL. Syst Rev 3:1\u201311","journal-title":"Syst Rev"},{"key":"3468_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades A, Ioannidis JP (2011) Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 64:163\u2013171","journal-title":"J Clin Epidemiol"},{"key":"3468_CR24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/0272989X12455847","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades A (2013) Evidence synthesis for decision making 4 inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making 33:641\u2013656","journal-title":"Med Decis Making"},{"key":"3468_CR25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","volume":"3","author":"J Higgins","year":"2012","unstructured":"Higgins J, Jackson D, Barrett J, Lu G, Ades A, White I (2012) Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods 3:98\u2013110","journal-title":"Res Synth Methods"},{"key":"3468_CR26","first-page":"285","volume":"3","author":"G Valkenhoef","year":"2012","unstructured":"Valkenhoef G, Lu G, Brock B, Hillege H, Ades A, Welton NJ (2012) Automating network meta-analysis. Research synthesis. Methods 3:285\u2013299","journal-title":"Methods"},{"key":"3468_CR27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","volume":"119","author":"LM Arnold","year":"2005","unstructured":"Arnold LM, Rosen A, Pritchett YL, D\u2019Souza DN, Goldstein DJ, Iyengar S, Wernicke JF (2005) A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119:5\u201315","journal-title":"Pain"},{"key":"3468_CR28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"IJ Russell","year":"2008","unstructured":"Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM (2008) Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136:432\u2013444","journal-title":"Pain"},{"key":"3468_CR29","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.clinthera.2008.11.009","volume":"30","author":"DJ Clauw","year":"2008","unstructured":"Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y (2008) Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 30:1988\u20132004","journal-title":"Clin Ther"},{"key":"3468_CR30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3899\/jrheum.090884","volume":"37","author":"JC Branco","year":"2010","unstructured":"Branco JC, Zachrisson O, Perrot S, Mainguy Y, Multinational Coordinator Study G (2010) A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol 37:851\u2013859","journal-title":"J Rheumatol"},{"key":"3468_CR31","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/art.27559","volume":"62","author":"LM Arnold","year":"2010","unstructured":"Arnold LM, Gendreau RM, Palmer RH, Gendreau JF, Wang Y (2010) Efficacy and safety of milnacipran 100\u00a0mg\/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum Arthritis Care Res 62:2745\u20132756","journal-title":"Arthritis Rheum Arthritis Care Res"},{"key":"3468_CR32","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","volume":"52","author":"LJ Crofford","year":"2005","unstructured":"Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, Young JP Jr, LaMoreaux LK, Martin SA, Sharma U, Pregabalin -105 Study G (2005) Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum Arthritis Care Res 52:1264\u20131273","journal-title":"Arthritis Rheum Arthritis Care Res"},{"key":"3468_CR33","first-page":"502","volume":"35","author":"PJ Mease","year":"2008","unstructured":"Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP Jr, Martin SA, Sharma U (2008) A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 35:502\u2013514","journal-title":"J Rheumatol"},{"key":"3468_CR34","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","volume":"9","author":"LM Arnold","year":"2008","unstructured":"Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP Jr, Sharma U, Martin SA, Barrett JA, Haig G (2008) A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 9:792\u2013805","journal-title":"J Pain"},{"key":"3468_CR35","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3899\/jrheum.110569","volume":"38","author":"L Pauer","year":"2011","unstructured":"Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, Leon T, Zeiher B, Investigators A (2011) An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. J Rheumatol 38:2643\u20132652","journal-title":"J Rheumatol"},{"key":"3468_CR36","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00296-014-2994-2","volume":"34","author":"F Catal\u00e1-L\u00f3pez","year":"2014","unstructured":"Catal\u00e1-L\u00f3pez F, Tob\u00edas A, Cameron C, Moher D, Hutton B (2014) Network meta-analysis for comparing treatment effects of multiple interventions: an introduction. Rheumatol Int 34:1489\u20131496","journal-title":"Rheumatol Int"},{"key":"3468_CR37","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/rheumatology\/kei031","volume":"44","author":"E Choy","year":"2005","unstructured":"Choy E, Smith C, Dore C, Scott D (2005) A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology 44:1414\u20131421","journal-title":"Rheumatology"},{"key":"3468_CR38","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/ard.2007.072652","volume":"67","author":"V Ravindran","year":"2008","unstructured":"Ravindran V, Scott D, Choy E (2008) A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis. Ann Rheum Dis 67:855\u2013859","journal-title":"Ann Rheum Dis"},{"key":"3468_CR39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-201249","volume":"72","author":"E N\u00fcesch","year":"2013","unstructured":"N\u00fcesch E, H\u00e4user W, Bernardy K, Barth J, J\u00fcni P (2013) Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis 72:955\u2013962","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3468-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3468-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3468-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:28:36Z","timestamp":1559028516000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3468-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["3468"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3468-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}